Search research articles
Contact Us
Filters
Showing results (71-80 of 80) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 80 results.
Molecular Cancer Research : MCR
|
August 6, 2020
Discrete Adaptive Responses to MEK Inhibitor in Subpopulations of Triple-Negative Breast Cancer
Daniel R Goulet, Joseph P Foster, Jon S Zawistowski, et al.
The Journal of Rheumatology
|
November 28, 2000
Underestimating the value of women: assessing the indirect costs of women with systemic lupus erythematosus. Tri-Nation Study Group
A E Clarke, J Penrod, Y St Pierre, et al.
Arthritis and Rheumatism
|
June 17, 2000
The use of alternative medical therapies in patients with systemic lupus erythematosus. Trination Study Group
A D Moore, M A Petri, S Manzi, et al.
The Journal of Rheumatology
|
November 16, 2001
Living with lupus: a prospective pan-Canadian study
P L Dobkin, D Da Costa, P R Fortin, et al.
Rheumatology (Oxford, England)
|
March 11, 2005
The systemic lupus erythematosus tri-nation study: longitudinal changes in physical and mental well-being
P Panopalis, M Petri, S Manzi, et al.
The Journal of Rheumatology
|
July 16, 1999
An international perspective on the well being and health care costs for patients with systemic lupus erythematosus. Tri-Nation Study Group
A E Clarke, M A Petri, S Manzi, et al.
Arthritis Care and Research : the Official Journal of the Arthritis Health Professions Association
|
November 18, 2000
Quality of life in systemic lupus erythematosus patients during more and less active disease states: differential contributors to mental and physical health
P L Dobkin, D Da Costa, M Dritsa, et al.
Oncotarget
|
April 13, 2018
Proteomic analysis defines kinase taxonomies specific for subtypes of breast cancer
Kyla A L Collins, Timothy J Stuhlmiller, Jon S Zawistowski, et al.
Cancer Discovery
|
January 22, 2017
Enhancer Remodeling during Adaptive Bypass to MEK Inhibition Is Attenuated by Pharmacologic Targeting of the P-TEFb Complex
Jon S Zawistowski, Samantha M Bevill, Daniel R Goulet, et al.
NPJ Breast Cancer
|
May 13, 2021
FOXA1 and adaptive response determinants to HER2 targeted therapy in TBCRC 036
Steven P Angus, Timothy J Stuhlmiller, Gaurav Mehta, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 80) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 80 results.
Molecular Cancer Research : MCR
|
August 6, 2020
Discrete Adaptive Responses to MEK Inhibitor in Subpopulations of Triple-Negative Breast Cancer
Daniel R Goulet, Joseph P Foster, Jon S Zawistowski, et al.
The Journal of Rheumatology
|
November 28, 2000
Underestimating the value of women: assessing the indirect costs of women with systemic lupus erythematosus. Tri-Nation Study Group
A E Clarke, J Penrod, Y St Pierre, et al.
Arthritis and Rheumatism
|
June 17, 2000
The use of alternative medical therapies in patients with systemic lupus erythematosus. Trination Study Group
A D Moore, M A Petri, S Manzi, et al.
The Journal of Rheumatology
|
November 16, 2001
Living with lupus: a prospective pan-Canadian study
P L Dobkin, D Da Costa, P R Fortin, et al.
Rheumatology (Oxford, England)
|
March 11, 2005
The systemic lupus erythematosus tri-nation study: longitudinal changes in physical and mental well-being
P Panopalis, M Petri, S Manzi, et al.
The Journal of Rheumatology
|
July 16, 1999
An international perspective on the well being and health care costs for patients with systemic lupus erythematosus. Tri-Nation Study Group
A E Clarke, M A Petri, S Manzi, et al.
Arthritis Care and Research : the Official Journal of the Arthritis Health Professions Association
|
November 18, 2000
Quality of life in systemic lupus erythematosus patients during more and less active disease states: differential contributors to mental and physical health
P L Dobkin, D Da Costa, M Dritsa, et al.
Oncotarget
|
April 13, 2018
Proteomic analysis defines kinase taxonomies specific for subtypes of breast cancer
Kyla A L Collins, Timothy J Stuhlmiller, Jon S Zawistowski, et al.
Cancer Discovery
|
January 22, 2017
Enhancer Remodeling during Adaptive Bypass to MEK Inhibition Is Attenuated by Pharmacologic Targeting of the P-TEFb Complex
Jon S Zawistowski, Samantha M Bevill, Daniel R Goulet, et al.
NPJ Breast Cancer
|
May 13, 2021
FOXA1 and adaptive response determinants to HER2 targeted therapy in TBCRC 036
Steven P Angus, Timothy J Stuhlmiller, Gaurav Mehta, et al.
Page
of 8